TONIZZO, ANNA
TONIZZO, ANNA
Universita' degli Studi di MILANO
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties
2024 A. Lombardi, L. Alagna, E. Palomba, G. Viero, A. Tonizzo, D. Mangioni, A. Bandera
Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
2023 G. Ancona, L. Alagna, C. Alteri, E. Palomba, A. Tonizzo, A. Pastena, A. Muscatello, A. Gori, A. Bandera
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
2023 A. Lombardi, G. Viero, S. Villa, S. Biscarini, E. Palomba, C. Azzara', N. Iannotti, B. Mariani, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, A. Grazia Valzano, L. Morlacchi, M. Francesca Donato, G. Castellano, R. Cassin, M. Carrabba, A. Muscatello, A. Gori, A. Bandera
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
2023 A. Lombardi, G. Viero, S. Villa, S. Biscarini, E. Palomba, C. Azzarà, N. Iannotti, B. Mariani, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, A. Grazia Valzano, L.C. Morlacchi, M. Francesca Donato, G. Castellano, R. Cassin, M. Carrabba, A. Muscatello, A. Gori, A. Bandera
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study
2022 S. Biscarini, S. Villa, C. Genovese, M. Tomasello, A. Tonizzo, M. Fava, N. Iannotti, M.M. Bolis, B. Mariani, A. Grazia Valzano, L.C. Morlacchi, F. Donato, G. Castellano, R. Cassin, M.D.R. Carrabba, A. Muscatello, A. Gori, A. Bandera, A. Lombardi
Nocardia Infections in the Immunocompromised Host: A Case Series and Literature Review
2022 E. Palomba, A. Liparoti, A. Tonizzo, V. Castelli, L. Alagna, G. Bozzi, R. Ungaro, A. Muscatello, A. Gori, A. Bandera